Taken together, to our knowledge, our findings provide the first in vivo evidence that this metabolic stressor by influencing tau metabolism is a pleiotropic and active modulator of the pathogenesis of AD and related tauopathies. The gene discussed is MAPT; the disease is tauopathy.